What Strategies Are Most Effective for Antibiotic Resistance Prevention?

Walk into most Nigerian pharmacies and ask the pharmacist about antibiotics. They’ll tell you stories. A patient demanding amoxicillin for a cough. Another one buying half a course because money ran out. A doctor prescribing broad-spectrum antibiotics for fever without any test results. These moments, repeated across Nigeria every single day, are where resistance actually builds.

Studies on antimicrobial stewardship in Nigeria show that prevention isn’t complicated. It’s deliberate. It starts with strategies that work in real settings, not theoretical approaches, but tactics that fit how Nigerian healthcare actually operates. So how can we actually stop resistance before it starts?

Key Strategies for Antibiotic Resistance Prevention

Strategy 1: Antibiotic Resistance Prevention Through Diagnostic Testing

Don’t prescribe what you’re not certain about. That’s the foundation. When doctors order tests before antibiotics, they stop treating guesses and start treating actual infections. Blood cultures, urinalysis, malaria tests- they take time, sure. But prescribing the right antibiotic from day one beats changing treatment midweek because nothing worked.

Strategy 2: Narrow-Spectrum Antibiotics When Possible

Broad-spectrum antibiotics are tempting. They work against almost everything. But they also train resistance almost everywhere. When a patient truly needs amoxicillin, not ciprofloxacin, prescribing narrow-spectrum saves the powerful drugs for when they’re actually needed.

Strategy 3: Complete Treatment Adherence

A five-day course of antibiotics stopped after three days is how resistance learns to survive. We educate patients on why finishing treatment matters, not as punishment, but as partnership. When patients understand that incomplete treatment leaves behind the strongest bacteria, compliance improves.

Strategy 4: Infection Prevention Stops Infections Before They Start

Hand hygiene, sanitation, and sterilization protocols prevent infections entirely, which means fewer antibiotics needed. A patient who never catches an infection doesn’t need treatment. Prevention in clinics saves antibiotics for actual emergencies.

Strategy 5: Monitoring Resistance Patterns Locally

What works in Lagos might not work the same way in Kano. Tracking which antibiotics are failing in your region means prescribers know which drugs are still reliable and which are losing power. This strategy transforms guesswork into data-driven decisions.

Strategy 6: Limiting Prophylactic Antibiotics to True Necessities

Preventive antibiotics before surgery make sense. For immunocompromised patients facing infection risk, they’re essential. But routine prophylaxis, giving antibiotics “just in case,” trains bacteria unnecessarily. When prophylactic antibiotics are reserved for actual high-risk situations, the drugs stay effective for emergencies instead of being wasted on routine prevention.

Strategy 7: Vaccination Programs

Pneumococcal vaccines, flu shots, and other immunizations prevent infections from developing in the first place. Prevention through vaccination is the most powerful antibiotic-sparing strategy available. When patients are protected from infections via vaccines, they never need antibiotics for those preventable diseases. This approach removes resistance risk entirely rather than trying to manage it after infection occurs.

Antimicrobial Stewardship Interventions That Enable Antibiotic Resistance Prevention

Strategies work only when coordinated through the entire facility. Antimicrobial Stewardship Interventions require clear guidelines, pharmacy verification of prescriptions, and consistent patient messaging. Without coordination between prescribers, pharmacists, and patients, individual strategies fail.

Facilities that succeed track prescribing patterns and adjust protocols based on resistance data. The role of pharmacists is critical; they flag deviations and maintain standards. Addressing Barriers to Antimicrobial Stewardship through institutional accountability transforms isolated choices into measurable outcomes that actually change behavior.

Barriers to Antimicrobial Stewardship That Stop Prevention

But this is where reality lives. Barriers to Antimicrobial Stewardship are real, and they’re structural.

System-Level Barriers to Prevention Success

Limited laboratory access means some clinics truly can’t test before prescribing. Financial pressure pushes patients to buy partial courses. Pharmaceutical companies profit from high-volume antibiotic sales. Patients distrust healthcare workers and self-treat instead. Adds the pressure on doctors, overwhelmed clinics, insufficient time per patient, limited drug options on shelves. 

A physician seeing fifty patients daily with limited diagnostics doesn’t have the luxury of waiting for test results. These aren’t moral failures. They’re system failures.

Pharmacy Barriers That Fuel Resistance Despite Prevention Efforts

Over-the-counter antibiotic sales without prescription requirements fuel resistance directly. Patients buying antibiotics for previous infections and using them for new symptoms. Partial courses left in homes, shared with family members. The infrastructure to control antibiotic flow doesn’t exist everywhere, and where it does exist, enforcement varies wildly. 

When pharmacies become convenience stores rather than healthcare checkpoints, resistance spreads faster than any intervention can contain it.

Addressing barriers means working within Nigeria’s healthcare reality instead of against it. Until we address why these barriers exist; poverty, limited access, weak regulation, prevention will always struggle uphill.

Strategy Works When Everyone Commits

What strategies actually work isn’t mysterious, it’s what happens when pharmacists, doctors, and patients all understand their role in stopping resistance. NNAST sees these strategies work every time commitment meets action. The question isn’t whether they’re effective. It’s whether we implement them consistently enough to matter.

Scroll to Top
akinsete-omobosola-1004-240x240-29843

Dr. Omobosola Akinsete is a dedicated physician and a key member of the Nigerian Antimicrobial Stewardship Taskforce. She has been an internal medicine and adult Infectious Disease physician in the United States of America for 30  years . She graduated from Medical school at the University of Lagos, and has a masters in Public Health from Johns Hopkins school of Public Health. 

She did her Internal Medicine training at a Brown University hospital and her fellowship in Infectious Diseases  at the University of Minnesota where she is an associate professor. She has worked with the National Institutes of Health and Howard University a a coordinator for the Human Genome Project among other projects, she is a frequent public speaker and contributor to different types of media. She loves to advocate for healthcare in minority populations. She  has a lot of experience with  patients and health care providers on antimicrobial stewardship in her institution  HealthPartners in Minnesota U.S.A. Her expertise in the field of Infectious diseases and antimicrobial stewardship and her passion to improve health care in her home country will contribute significantly to the fight against antimicrobial resistance in Nigeria. Dr. Akinsete’s work with the taskforce focuses on leadership of the taskforce as chairperson and national coordinator, working closely with NCDC leadership, the Nigerian Federal Ministry of Health, stakeholders, and funding partners, and helping with capacity building of standardized antimicrobial stewardship and infectious disease educational programs. She will also use her expertise to guide providers and HealthCare institutions  on the ground . Her commitment to improving antimicrobial use and patient safety is invaluable to the nation’s public health efforts.